In Japanese patients with reflux esophagitis , omeprazole 20 mg is more effective than rabeprazole 10 mg at achieving early , sufficient , sustained reflux symptom relief in individuals with the CYP2C19 PM phenotype , and is similarly effective to rabeprazole 10 mg in those with heteroEM or homoEM phenotypes .